5 Key Takeaways

• 1

  The AHA, AAP, ACOG, and SMFM developed a coordinated framework for cardiovascular risk assessment in girls and women.

• 2

  The framework identifies perimenarche, ovarian cycling, perimenopause, and postmenopause as 4 hormonally defined life stages for risk assessment.

• 3

  Menstrual abnormalities, pregnancy complications, and menopausal transitions are identified as opportunities for earlier cardiovascular risk assessment.

• 4

  Pregnancy complications, including preeclampsia and gestational diabetes, are recognized as cardiovascular risk enhancers, but only about 60% of affected women receive hypertension follow-up within 6

• 5

  The societies propose a national network of Comprehensive Centers of Excellence for Women's Cardiovascular Care, combining clinical care, education, research, and community engagement.